Top legal experts: Laws protecting IP aren’t tools for drug price controls
Legislation to encourage innovation and protect patent holders should not be distorted into
Read More 
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers
At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back
Read More 
Amicus Therapeutics wins FDA approval for breakthrough late-onset Pompe therapy
The U.S. Food and Drug Administration (FDA) has approved a therapy used for
Read More 
Climate change is threatening rice farming—can crops be kept afloat?
Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and
Read More 
BIO surveying biotech firms on how to improve communications with the FDA
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with
Read More 
Battling sepsis and superbugs requires awareness and policy
Generated by our own internal defenses, sepsis claims 350,000 adult lives each year
Read More EDITORS' CHOICE
Meet the biotech sisterhood—women supporting women in the pharma sector
“The biotech sisterhood is the antidote to the pharma bros,” said Angie You, Ph.D., Chief Executive Officer at Architect Therapeutics, during a lively conversation with
Read More 
LATEST NEWS
Diversity, Equity, Inclusion
This Hispanic Heritage Month comes with opportunities, challenges, and a chance to reflect
Hispanic Heritage Month, from September 15 to October 15, serves as an important opportunity to remember and honor the contributions of the Hispanic community to
Federal Policy
Top legal experts: Laws protecting IP aren’t tools for drug price controls
Legislation to encourage innovation and protect patent holders should not be distorted into instruments for drug price controls, a high-profile group of former judges, federal
Bioeconomy
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers
At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused for
Health
Amicus Therapeutics wins FDA approval for breakthrough late-onset Pompe therapy
The U.S. Food and Drug Administration (FDA) has approved a therapy used for the treatment of late-onset Pompe disease (LOPD). The two-component therapy is manufactured
Agriculture
Climate change is threatening rice farming—can crops be kept afloat?
Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and animals are equally affected, as rising temperatures raise concerns among farmers. One
HEALTH
BIO to Congress: IRA's price controls harm R&D
Drug price controls in the Inflation Reduction Act (IRA) harm drug R&D, John Crowley, CEO of Amicus Therapeutics and BIO Board Vice Chair, testified on September 21.
AGRICULTURE
Climate Change
Climate change is threatening rice farming—can crops be kept afloat?
Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and animals are equally affected, as rising temperatures
Read More 
Federal Policy
State Policy
This Hispanic Heritage Month comes with opportunities, challenges, and a chance to reflect
Hispanic Heritage Month, from September 15 to October 15, serves as an important opportunity to remember and honor the contributions
Read More 
International
Bio's View
BIO surveying biotech firms on how to improve communications with the FDA
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with the Food and Drug Administration (FDA), with
Read More 
